BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16921652)

  • 1. Overcoming stigma to seek help for Alzheimer's.
    Johns Hopkins Med Lett Health After 50; 2006 Aug; 18(6):6-7. PubMed ID: 16921652
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management and therapy of Alzheimer's disease. Recommendations of a general practitioners' guideline].
    Vollmar HC; Wilm S
    MMW Fortschr Med; 2009 Jun; 151(24):36-40; quiz 41. PubMed ID: 19645200
    [No Abstract]   [Full Text] [Related]  

  • 3. Help for early Alzheimer's.
    Johns Hopkins Med Lett Health After 50; 2004 May; 16(3):1-2, 7. PubMed ID: 15132095
    [No Abstract]   [Full Text] [Related]  

  • 4. [The characteristics of Alzheimer's Disease Units in relation to neuropsychological tests].
    Sorrentino GC; Caffari B; Vanacore N; Maggini M; Raschetti R
    Ann Ist Super Sanita; 2005; 41(1):63-8. PubMed ID: 16037652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 6. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM; Farlow MR
    Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
    [No Abstract]   [Full Text] [Related]  

  • 7. Latest approaches in Alzheimer's care.
    Nadler-Moodie M; Wilson MF
    RN; 1998 Jul; 61(7):42-5; quiz 46. PubMed ID: 9687816
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy in Alzheimer disease].
    Kovács T
    Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes of Alzheimer's disease treatment: the Italian CRONOS project.
    Bianchetti A; Padovani A; Trabucchi M
    Int J Geriatr Psychiatry; 2003 Jan; 18(1):87-8. PubMed ID: 12497562
    [No Abstract]   [Full Text] [Related]  

  • 10. Stigma and Alzheimer's disease: causes, consequences and a constructive approach.
    Jolley DJ; Benbow SM
    Int J Clin Pract; 2000 Mar; 54(2):117-9. PubMed ID: 10824368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stigma by association and Alzheimer's disease.
    Werner P; Heinik J
    Aging Ment Health; 2008 Jan; 12(1):92-9. PubMed ID: 18297483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of neuropsychological tests in the Cronos Project].
    Bianchi G; Gasparini M; Caffari B; Sorrentino GC; Bianchi C; Bruno G; Maggini M; Raschetti R; Vanacore N
    Ann Ist Super Sanita; 2005; 41(1):69-74. PubMed ID: 16037653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical treatment of Alzheimer's disease].
    Andersen SE
    Ugeskr Laeger; 2006 Oct; 168(44):3833; author reply 3833. PubMed ID: 17131519
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dementia--treatment].
    Stoppe G; Stiens G; Staedt J
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1544-6; quiz 147-50. PubMed ID: 12854065
    [No Abstract]   [Full Text] [Related]  

  • 15. Subjective experience of family stigma as reported by children of Alzheimer's disease patients.
    Werner P; Goldstein D; Buchbinder E
    Qual Health Res; 2010 Feb; 20(2):159-69. PubMed ID: 20065304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac effects of cholinesterase inhibitors: a reason for restraint?].
    Salarbaks AM; Boomkamp-Snoeren CM; van Puijenbroek E; Jansen PA; van Marum RJ
    Tijdschr Gerontol Geriatr; 2009 Apr; 40(2):79-84. PubMed ID: 19472574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric outcome for clinical trials.
    Robert P; Verhey FR; Aalten P; Cortes F; Byrne EJ
    J Nutr Health Aging; 2007; 11(4):345-7. PubMed ID: 17653496
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical inquiries. Do patients at high risk of Alzheimer's disease benefit from early treatment?
    Holt J; Stiltner L; Wallace R; Raetz J
    J Fam Pract; 2009 Jun; 58(6):320-2. PubMed ID: 19508846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caregiver acceptance of adverse effects and use of cholinesterase inhibitors in Alzheimer's disease.
    Oremus M; Wolfson C; Vandal AC; Bergman H; Xie Q
    Can J Aging; 2007; 26(3):205-12. PubMed ID: 18238727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choosing treatment for Alzheimer's patients and their caregivers.
    Schneider LS; Porsteinsson AP; Peskin ER; Pfeiffer EA
    Geriatrics; 2003 Aug; 58 Suppl 1():3-18, 23; quiz 19-22. PubMed ID: 12961833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.